Inscription Capital »

Vertex Pharmaceuticals Incorporated shares owned by Inscription Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Inscription Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $385k 827 465.08
2024-06-30 $392k 837 468.72
2024-03-31 $235k 562 418.01
2023-12-31 $229k 562 406.89

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Bank of America Corporation (BAC)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Nike CL B (NKE)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Chevron Corporation (CVX)
Ishares Tr Intl Trea Bd Etf (IGOV)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)

View all positions for Inscription Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated